share_log

Flora Growth Analyst Ratings

Benzinga Analyst Ratings ·  Feb 1, 2023 11:53
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/01/2023 885.55% Argus Research → $3 Maintains Buy
10/25/2022 557.03% Alliance Global Partners $2.5 → $2 Maintains Buy
09/23/2022 721.29% Alliance Global Partners → $2.5 Initiates Coverage On → Buy
08/01/2022 179.24% Cantor Fitzgerald → $0.85 Initiates Coverage On → Neutral
10/13/2021 3185.15% Roth Capital → $10 Initiates Coverage On → Buy
06/23/2021 1871.09% MKM Partners → $6 Initiates Coverage On → Buy

What is the target price for Flora Growth (FLGC)?

The latest price target for Flora Growth (NASDAQ: FLGC) was reported by Argus Research on February 1, 2023. The analyst firm set a price target for $3.00 expecting FLGC to rise to within 12 months (a possible 885.55% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Flora Growth (FLGC)?

The latest analyst rating for Flora Growth (NASDAQ: FLGC) was provided by Argus Research, and Flora Growth maintained their buy rating.

When is the next analyst rating going to be posted or updated for Flora Growth (FLGC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Flora Growth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Flora Growth was filed on February 1, 2023 so you should expect the next rating to be made available sometime around February 1, 2024.

Is the Analyst Rating Flora Growth (FLGC) correct?

While ratings are subjective and will change, the latest Flora Growth (FLGC) rating was a maintained with a price target of $0.00 to $3.00. The current price Flora Growth (FLGC) is trading at is $0.30, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment